.
All is not lost in the current bear run on Dalal Street, as close to Rs 1.5 trillion have been added to investors' wealth by over 100 companies, including blue-chips like Infosys, Cairn India, Satyam and Ranbaxy and also some little known smaller firms.
While a few of these companies have registered a growth of nearly two-fold or three-fold, a number of them have seen their values growing by more than 10 per cent with an average surge of nearly 15 per cent.
The stock market has been mostly on a downslide for close to six months now and its benchmark Sensex as well as total valuation has dipped by close to a third since January 10.
The barometer index, Sensex, had scaled a life-time high of 21,206.77 points on January 10 before embarking on a southward journey losing close to 8,000 points till now.
A number of large-cap companies have seen their valuations dip sharply – with a loss of close to Rs 5 trillion by companies headed by the country's five richest individuals – Mukesh and Anil Ambani, K P Singh, Azim Premji and Sunil Mittal. The net loss has been more than Rs 25 trillion for all the listed entities in the country.
However, an estimated 114 companies have actually seen their market value growing in this period, shows an analysis of change in M-cap figures since January 10.
In absolute terms, these companies have seen their market capitalisation growing by close to Rs 46,000 crore to more than Rs 3,54,000 crore.
However, just about 30 companies out of these have a market capitalisation of more than Rs 1,000 crore and the growth has been mostly in single or double-digit percentage points for these firms.
In absolute terms, the biggest gain of close to Rs 9,000 crore has been for Infosys, followed by over Rs 5,000 crore for Sun Pharma and Ranbaxy. Besides, companies like Cairn India, Satyam, Glenmark Pharma and Sterling Intl have also seen a surge of about Rs 2,000-4,000 crore.
Other major gainers in this period include Cipla, Nestel India, GlaxoSmithKline, REI Agro, Spice Communications and ICI India, BOC India and Temptation Foods.
In percentage terms, the growth has been relatively modest at about 10 per cent for companies like Infosys, Cairn, Satyam and relatively better at 25-35 per cent for Sun Pharma and Ranbaxy.
However, companies like Sterling Intl, Zandu Pharma, Khaitan Weaving, Sandur Manganese, Gujarat Foils, Champagne Vine, KLG Capital, Choksh Infotech and Rollatainers have seen a gravity-defying surge with their market values more than doubling in this period.